Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Convertible Debt (2017)

Historic Convertible Debt for Neuroone Medical Technologies (NMTC) over the last 4 years, with Q3 2017 value amounting to $1.6 million.

  • Neuroone Medical Technologies' Convertible Debt changed N/A to $1.6 million in Q3 2017 from the same period last year, while for Sep 2017 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $6000.0 for FY2013, which is 8923.38% down from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Convertible Debt of $1.6 million as of Q3 2017.
  • In the past 5 years, Neuroone Medical Technologies' Convertible Debt registered a high of $1.6 million during Q3 2017, and its lowest value of $6000.0 during Q4 2013.